Camille Grasmuck

Camille Grasmuck

Auto-generated profile, based on publicly available information

Camille Grasmuck

Department of Neuroscience, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YKYousra Khalfallah
Yousra Khalfallah
RKRachel Kuta
Rachel Kuta
CGCamille Grasmuck
Camille Grasmuck
APAlexandre Prat
Alexandre Prat
HDHeather D. Durham
Heather D. Durham
CVChristine Vande Velde
Christine Vande Velde
Stress granules (SGs) are cytoplasmic foci that form in response to various external stimuli and are essential to cell survival following stress. SGs are studied in several diseases, including ALS and FTD, which involve the degeneration of motor and cortical neurons, respectively, and are now realized to be linked pathogenically by TDP-43, originally discovered as a component of ubiquitin-positive aggregates within patients’ neurons and some glial cells. So far, studies to undercover the role of TDP-43 in SGs have used primarily transformed cell lines, and thus rely on the extrapolation of the mechanisms to cell types affected in ALS/FTD, potentially masking cell specific effects. Here, we investigate SG dynamics in primary motor and cortical neurons as well as astrocytes. Our data suggest a cell and stress specificity and demonstrate a requirement for TDP-43 for efficient SG dynamics. In addition, based on our in vitro approach, our data suggest that aging may be an important modifier of SG dynamics which could have relevance to the initiation and/or progression of age-related neurodegenerative diseases.

13 November 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
LMLaure Michel
Laure Michel
CGCamille Grasmuck
Camille Grasmuck
MCMarc Charabati
Marc Charabati
Marc-André LécuyerMarc-André Lécuyer
Marc-André Lécuyer
SZStephanie Zandee
Stephanie Zandee
APAlexandre Prat
Alexandre Prat
The presence of B lymphocyte–associated oligoclonal immunoglobulins in the cerebrospinal fluid is a classic hallmark of multiple sclerosis (MS). The clinical efficacy of anti-CD20 therapies supports a major role for B lymphocytes in MS development. Although activated oligoclonal populations of pathogenic B lymphocytes are able to traffic between the peripheral circulation and the central nervous system (CNS) in patients with MS, molecular players involved in this migration have not yet been elucidated. In this study, we demonstrated that activated leukocyte cell adhesion molecule (ALCAM/CD166) identifies subsets of proinflammatory B lymphocytes and drives their transmigration across different CNS barriers in mouse and human. We also showcased that blocking ALCAM alleviated disease severity in animals affected by a B cell–dependent form of experimental autoimmune encephalomyelitis. Last, we determined that the proportion of ALCAM+ B lymphocytes was increased in the peripheral blood and within brain lesions of patients with MS. Our findings indicate that restricting access to the CNS by targeting ALCAM on pathogenic B lymphocytes might represent a promising strategy for the development of next-generation B lymphocyte–targeting therapies for the treatment of MS.

11 January 2019 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
TDTessa Dhaeze
Tessa Dhaeze
LTLaurence Tremblay
Laurence Tremblay
CLCatherine Lachance
Catherine Lachance
EPEvelyn Peelen
Evelyn Peelen
SZStephanie Zandee
Stephanie Zandee
APAlexandre Prat
Alexandre Prat

5 January 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
MCMarc Charabati
Marc Charabati
CGCamille Grasmuck
Camille Grasmuck
SGSoufiane Ghannam
Soufiane Ghannam
LBLyne Bourbonnière
Lyne Bourbonnière
AFAntoine P. Fournier
Antoine P. Fournier
APAlexandre Prat
Alexandre Prat
DICAM contributes to the pathogenesis of autoimmune neuroinflammation by promoting the migration of T H 17 lymphocytes across the blood-brain barrier.

15 April 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
RRRose-Marie Rébillard
Rose-Marie Rébillard
MCMarc Charabati
Marc Charabati
CGCamille Grasmuck
Camille Grasmuck
AFAbdelali Filali-Mouhim
Abdelali Filali-Mouhim
OTOlivier Tastet
Olivier Tastet
CLCatherine Larochelle
Catherine Larochelle
Dysregulated immune profiles have been described in symptomatic patients infected with SARS-CoV-2. Whether the reported immune alterations are specific to SARS-CoV-2 infection or also triggered by other acute illnesses remains unclear. We performed flow cytometry analysis on fresh peripheral blood from a consecutive cohort of (a) patients hospitalized with acute SARS-CoV-2 infection, (b) patients of comparable age and sex hospitalized for another acute disease (SARS-CoV-2 negative), and (c) healthy controls. Using both data-driven and hypothesis-driven analyses, we found several dysregulations in immune cell subsets (e.g., decreased proportion of T cells) that were similarly associated with acute SARS-CoV-2 infection and non–COVID-19-related acute illnesses. In contrast, we identified specific differences in myeloid and lymphocyte subsets that were associated with SARS-CoV-2 status (e.g., elevated proportion of ICAM-1+ mature/activated neutrophils, ALCAM+ monocytes, and CD38+CD8+ T cells). A subset of SARS-CoV-2–specific immune alterations correlated with disease severity, disease outcome at 30 days, and mortality. Our data provide an understanding of the immune dysregulation specifically associated with SARS-CoV-2 infection among acute care hospitalized patients. Our study lays the foundation for the development of specific biomarkers to stratify SARS-CoV-2–positive patients at risk of unfavorable outcomes and to uncover candidate molecules to investigate from a therapeutic perspective.

21 March 2019 in JCI Insight
Verified
Journal Article
Closed access
PDF file
TDTessa Dhaeze
Tessa Dhaeze
CLCatherine Lachance
Catherine Lachance
LTLaurence Tremblay
Laurence Tremblay
CGCamille Grasmuck
Camille Grasmuck
LBLyne Bourbonnière
Lyne Bourbonnière
APAlexandre Prat
Alexandre Prat
TCR 1640 mice, which have a T cell receptor (TCR) directed against MOG 92–106 , spontaneously develop experimental autoimmune encephalomyelitis. Female mice mostly develop a relapsing-remitting (RR) course and have a higher incidence of disease, while males most frequently suffer from progressive disease, reflecting the unresolved clinical sex discrepancies seen in multiple sclerosis. Herein, we performed adoptive transfers of male and female TCR 1640 immune cells into WT animals to investigate if disease course is dependent on the sex of the donor immune cells or on the sex of the recipient animal. We found that transfer of female TCR 1640 immune cells led to a RR disease while transfer of male TCR 1640 immune cells led to a progressive course, independent of the sex of the recipient. In addition, regulatory and pathogenic T cell infiltration after transfer was also immune cell sex intrinsic. We performed genetic profiling of the donor immune cells and found significant differences between the transcriptomic profiles of male and female TCR 1640 immune cells, interestingly, within genes related to immune regulation of T lymphocytes. These results suggest that differences in gene expression profiles related to regulation of T cell immunity seen in male and female neuroinflammatory disease drive relapsing versus progressive disease course.